The philanthropic state: Market-state hybrids in the philanthrocapitalist turn

Third World Quarterly

Volumn 35, Issue 1, 2014, Pages 109-125

  McGoey, Linsey ^a  

^a UNIVERSITY OF ESSEX   (United Kingdom)

Author keywords

advanced market commitments; financialisation; global health; philanthrocapitalism; public private partnerships; risk reward nexus

Indexed keywords

EID: 84893899814     PISSN: 01436597     EISSN: 13602241     Source Type: Journal    
DOI: 10.1080/01436597.2014.868989     Document Type: Article

References (57)

1. Banerjee, A., E. Duflo, R. Glennester, and C. Kinnan. The Miracle of Microfinance? Evidence from a Randomized Evaluation. Poverty Action Lab Working Paper. 2009. http://economics.mit.edu/files/4162.
2. Bank, D. Breaking Windows: How Bill Gates Fumbled the Future of Microsoft. New York: Free Press, 2001.
3. Birn, A.-E., and J. Lexchin. "Beyond Patents." Human Vaccines 7, no. 3 (2011): 1-2.
4. Bishop, M., and M. Green. Philanthrocapitalism: How the Rich can Save the World. London: Bloomsbury Press, 2008.
5. Blackburn, R. "Finance and the Fourth Dimension." New Left Review 39, May/June (2006): 39-70.
6. Bornstein, E. "The Impulse of Philanthropy." Cultural Anthropology 24, no. 4 (2009): 622-651.
7. Brenner, R. "The Economics of Global Turbulence: A Special Report on the World Economy, 1950-98." New Left Review 229, May/June (1998): 1-265.
8. Buse, K., and A. Harmer. "Power to the Partners? The Politics of Public-Private Health Partnerships." Development 47, no. 1 (2004): 49-56.
9. Buse, K., and G. Walt. "Global Public-Private Partnerships: Part I - A New Development in Health?" Bulletin of the World Health Organization 78, no. 4 (2000): 549-561.
10. Buse, K., and G. Walt. "Global Public-Private Partnerships: Part II - A New Development in Health?" Bulletin of the World Health Organization 78, no. 5 (2000): 699-709.
11. Collins, K. "Africa's First Bitcoin Wallet Launches in Kenya." Wired, July 9, 2013. Crutchfield, L., J. Kania, and M. Kramer. Do More than Give: The Six Practices of Donors Who Change the World. San Francisco: Jossey-Bass, 2011.
12. Edwards, M. Small Change: Why Business won't Change the World. New York: Demos, 2010.
13. Farlow, A. "Over the Rainbow: The Pot of Gold for Neglected Diseases." Lancet 364 (2004): 2011-2012.
14. Garrett, L. "Money or Die: A Watershed Moment for Global Public Health." Foreign Affairs, March 6, 2012.
15. Guilhot, N. "Reforming the World: George Soros, Global Capitalism and the Philanthropic Management of the Social Sciences." Critical Sociology 33 (2007): 447-477.
16. Guari, V., and P. Khaleghian. "Immunization in Developing Countries: Its Political and Organizational Determinants." World Development 30, no. 12 (2002): 2109-2132.
17. Harman, S. "Innovation and the Perils of Rebranded Privatisation: The Case of Neoliberal Global Health." In Handbook of the International Political Economy of Governance, eds. A. Payne, and N. Phillips. Cheltenham: Edward Elgar, 2014.
18. Hollis, A. "The Health Impact Fund: A Useful Supplement to the Patent System?" Public Health Ethics 1 (2008): 124-133.
19. Institute for Health Metrics and Evaluation (ihme). Financing Global Health 2012: The End of the Golden Era? Seattle, WA: IHME, 2012.
20. Jenkins, G. "Who's Afraid of Philanthrocapitalism?" Case Western Reserve Law Review 61, no. 3 (2011): 753-821.
21. Katz, S. "What does it Mean to Say that Philanthropy is 'Effective?' The Philanthropists' New Clothes." Proceedings of the American Philosophical Society 149, no. 2 (2005): 123-131.
22. Koh, H., A. Karamchandani, and R. Katz, From Blueprint to Scale: The Case for Philanthropy in Impact Investing. Monitor Group, April 2012. http://www.mim.monitor.com/blueprinttoscale.html.
23. Krause, M. The Good Project: Humanitarian Relief NGOs and the Fragmentation of Reason. Chicago, IL: University of Chicago Press, 2014.
24. Kremer, M., and R. Glennerster. Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases. Princeton, NJ: Princeton University Press, 2004.
25. Krippner, G. "The Financialization of the American Economy." Socio-Economic Review 3 (2005): 173-208.
26. Lazonick, W., and M. Mazzucato. "The Risk-Reward Nexus in the Innovation-Inequality Relationship: Who Takes the Risks? Who Gets the Rewards?" Industrial and Corporate Change 22, no. 4 (2013): 1093-1128.
27. Lexchin, J. "One Step Forward, One Step Sideways? Expanding Research Capacity of Neglected Diseases." Bmc International Health and Human Rights 10 (2010). doi:10.1186/1472-698X-10-20.
28. Light, D. "Making Practice Markets for Vaccines." Plos [Public Library of Science] Medicine. 10 (2005): 0934-0938.
29. Light, D., and R. Warburton. "Demythologizing the High Costs of Pharmaceutical Research." Biosocieties 6 (2011): 34-50.
30. Love, J. "Assessment of Additional Global Partnerships in the Areas of Access to Essential Medicines, Debt Relief and Transfer of Technology," Presentation on the Global Fund and TDR. Report to the Human Rights Council. United Nations, Geneva, April 1-9, 2009.
31. Martin, R., and S. Osberg. "Social Entrepreneurship: The Case for Definition." Stanford Social Innovation Review Spring (2007): 27-39.
32. Mazzucato, M. The Entrepreneurial State: Debunking Public vs Private Sector Myths. London: Anthem Press, 2013.
33. McCambridge, R. "Social Entrepreneurship and Social Innovation: Are They Potentially in Conflict?" Non-profit Quarterly 25 December 2011.
34. McCoy, D., G. Kembhavi, J. Patel, and A. Luintel. "The Bill and Melinda Gates Foundation's Grant-making Programme for Global Health." Lancet 373 (2009): 1645-1653.
35. McGoey, L., J. Reiss, and A. Wahlberg. "The Global Health Complex." Biosocieties 6, no. 1 (2011): 1-9.
36. McGoey, L. "Philanthrocapitalism and its Critics." Poetics 40, no. 2 (2012): 185-199.
37. Milberg, W. "Shifting Sources and Uses of Profits: Sustaining US Financialization with Global Value Chains." Economy and Society 37, no. 3 (2008): 420-451.
38. Moran, M. Private Foundations and Development Partnerships: American Philanthropy and Global Development Agendas. London: Routledge, 2013.
39. Nicholls, A. "The Institutionalization of Social Investment: The Interplay of Investment Logics and Investor Rationalities." Journal of Social Entrepreneurship 1, no. 1 (2010): 70-100.
40. Palmås, K. "Re-assessing Schumpeterian Assumptions Regarding Entrepreneurship and the Social." Social Enterprise Journal 8, no. 2 (2012): 141-155.
41. Palley, T. Financialization: What it is and Why it Matters." Working Paper 525. Levy Economics Institute, 2007.http://www.levyinstitute.org/pubs/wp_525.pdf
42. Perlroth, N., and M. Noer, eds. "World's Most Powerful People." Forbes November 2, 2011.
43. Richey, L., and S. Ponte. Brand Aid: Shopping Well to Save the World. Minneapolis: University of Minnesota Press, 2011.
44. Ridley, D., H. Grabowski, and J. Moe "Developing Drugs for Developing Countries. Health Affairs 25 (2006): 313-324.
45. Schumpeter, J. Capitalism, Socialism and Democracy. 1962. Reprint, New York: Harper & Row, 1975.
46. Scudellari, M. "Are Advance Market Committments for Drugs a Real Advance?" Nature Medicine 17 (2011): 139.
47. Shah, A. "Foreign Aid for Development Assistance." Globalissues.org. Accessed April 8, 2012 http://www.globalissues.org/print/article/35.
48. Sinclair, H. Confessions of a Microfinance Heretic: How Microlending Lost Its Way and Betrayed the Poor. San Francisco: Berrett-Koehler Publishers, 2012.
49. Skoll, J. "Preface." In Nicholls, A., ed. Social Entrepreneurship: New Models of Sustainable Social Change. Oxford: Oxford University Press, 2006.
50. Stuckler, D., S. Basu, and M. McKee. "Global Health Philanthropy and Institutional Relationships: How Should Conflicts of Interest be Addressed?" PLOS Medicine 8 (2011): c1001020.
51. Trouiller, P., P. Olliaro, E. Torreele, J. Orbinski, R. Laing, and N. Ford. "Drug Development for Neglected Diseases: A Deficient Market and Public-health Policy Failure." Lancet 359 (2002): 2188-2194.
52. Usher, A. D. "Dispute over Pneumococcal Vaccine Initiative." Lancet 374 (2009): 1879-1880.
53. Villadsen, K. "The Emergence of 'Neo-philanthropy': A New Discursive Space in Welfare Policy?" Acta Sociologica 50 (2007): 309-323.
54. Watkins, S., A. Swidler, and T. Hannan. "Outsourcing Social Transformation: Development NGOs as Organizations." Annual Review of Sociology 38 (2012): 285-315.
55. Whitehead, E. "Africa: Aiding Business." All Africa, January 5, 2012.
56. Youde, J. "The Rockefeller and Gates Foundations in Global Health Governance." Global Society 27, no. 2 (2013): 139-158.
57. Zunz, O. Philanthropy in America: A History. Princeton, NJ: Princeton University Press, 2011.